Perfuze announced today that it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also announced a new personnel appointment, naming Joe Rotger EVP of sales. According to a news release, Perfuze completed enrollment in the MARRS (millipede aspiration for revascularization in stroke) study. The study enrolled […]
Perfuze
Perfuze wins FDA nod for access catheter, raises $24M
Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding. The Galway, Ireland–based medtech company picked up about $24 million (€22 million) in a follow-on funding round. Existing investors, including Earlybird, EQT Life Sciences, Seroba and SV Health, participated in the round. The company earmarked funds to […]
FDA clears neurovascular aspiration, access catheters from Perfuze
Perfuze announced today that the FDA cleared its Millipede 070 aspiration catheter and second-generation Millipede 088 access catheter. Galway, Ireland-based Perfuze developed Millipede 070 to address critical unmet needs in ischemic stroke treatment. It aims to remove clots rapidly and safely through a novel, unique catheter. Millipede 070 has a unique design with a rib-and-recess […]
Perfuze wins CE mark approval for clot aspiration catheter, treats first patients
Perfuze today said it received CE mark approval for its clot aspiration catheter Millipede 088. The Ireland-based company also announced that the first five acute ischemic stroke patients have been treated with the device. Get the full story on our sister site, Medical Tubing + Extrusion.
Perfuze lands breakthrough designation for Millipede clot ingestion system
Perfuze yesterday announced that the FDA granted its Millipede CIS technology Breakthrough Device Designation. Millipede CIS is a catheter technology that removes clots from the brain after an acute ischemic stroke. The Breakthrough Device Designation was granted based on its potential to offer advantages over other alternative treatment of acute ischemic stroke, according to the […]
Perfuze raises $3m seed round for Millipede stroke catheter
Perfuze said today that it raised more than $3 million for the Millipede catheter it’s developing to treat ischemic stroke. Although not quite in stealth mode, the Galway, Ireland-based firm is close-mouthed about its technology. CEO Wayne Allen and CTO Liam Mullins (who co-founded Embo Medical before its in 2015, $YY acquisition by C.R. Bard in 2015) founded […]
